Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, Vensana Capital is a venture capital and growth equity firm based in the United States. The firm manages a portfolio of 20 companies, focusing exclusively on the healthcare and biotech sectors. Vensana Capital partners with entrepreneurs to drive innovation in medical technology.
Vensana Capital invests in development and commercial stage companies within the medtech sector, including medical devices, diagnostics, data science, drug delivery, digital health, life science tools, and tech-enabled services. Their investment stages range from pre-seed to growth equity, allowing them to support companies at various points in their lifecycle.
Notable companies in Vensana Capital's portfolio include PhaseBio Pharmaceuticals and Senseonics, both of which have gone public. The firm has also supported several acquisitions, including Cartiva, CV Ingenuity, and Intact Vascular.
Submit your pitch through their form at vensanacap.com.
As of October 2023: Vensana Capital has highlighted significant developments in their portfolio, including the IPO of SpyGlass Pharma and funding rounds for Ventaris Surgical and Apella.
Yes, Vensana Capital often leads investment rounds, particularly in their focus areas within the medtech sector.
The firm actively participates in follow-on investments to support the growth of their portfolio companies.
Specific fund size details are not publicly available, but Vensana Capital has a diverse portfolio across multiple investment stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.